Tirzepatide — ≥99% Research Peptide
Dual-Action GIP/GLP-1 — Next-Gen Metabolic Peptide
Tirzepatide is the first dual GLP-1/GIP receptor agonist. It simultaneously activates two incretin receptors, producing synergistic effects that exceed either pathway alone.
Research Applications & Benefits
- Dual GIP + GLP-1 receptor activation
- Enhanced metabolic signaling
- Superior appetite regulation
- Advanced blood sugar management
Product Specifications
- Compound
- Tirzepatide
- CAS Number
- 2023788-19-2
- Molecular Weight
- 4813.45 g/mol
- HPLC Purity
- ≥99% (independently verified by CertikLabs)
- Category
- GLP-1 & Metabolic
- Starting Price
- $119.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Every Tirzepatide batch sold by PeptidesDirect is independently tested for purity (HPLC), identity (LC-MS), and concentration. A batch-specific Certificate of Analysis is available on request and anchored to a CertikLabs verification record for public inspection.
Frequently Asked Questions
Is Tirzepatide suitable for human consumption?
No. Tirzepatide is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.
What purity is Tirzepatide?
Tirzepatide ships at ≥99% verified by reverse-phase HPLC with mass-spec identity confirmation on every batch.
How is Tirzepatide shipped and stored?
Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
